Inez de Greef-van der Sandt

Inez de Greef-van der Sandt is a seasoned professional in the biotech and pharmaceutical sectors, serving as Co-founder and Managing Partner of 3D-PharmXchange since 2010, where integrated drug development and project management solutions are provided. Inez has also been the CEO of Treeway since 2013, focusing on therapies for neurodegenerative diseases such as ALS and Alzheimer's Disease. In addition, Inez holds a Fellow position at the Netherlands Academy of Engineering, contributes to various advisory boards including the Member Advisory Board Topsector Life Science Health, and participates in the Industry Advisory Board of HEALTH-RI, fostering innovation in healthcare through data utilization. With a strong educational background including a PhD in Pharmacology from Leiden University, Inez has played a pivotal role in advancing research funding and collaboration through various initiatives and committees, including the ALS Research Forum and the ALS Investment Fund.